Mirati Therapeutics Inc

MRTX

Sector
Healthcare

Industry
Biotechnology

Website
mirati.com




Buy / Sell (dollars)

1 Month

4.5% 4.5% Complete (success)
95.5% 95.5% Complete (danger)
$533,570.24
avg. $533,570.24
$11.383M
avg. $11.383M

Buy/Sell Ratio

0.047

Transactions

17

Filers

4

3 Month

0.6% 0.6% Complete (success)
99.4% 99.4% Complete (danger)
$534,295.25
avg. $178,098.42
$82.652M
avg. $27.551M

Buy/Sell Ratio

0.006

Transactions

21

Filers

7

12 Month

5% 5% Complete (success)
95% 95% Complete (danger)
$12.215M
avg. $1.018M
$234.405M
avg. $19.534M

Buy/Sell Ratio

0.052

Transactions

92

Filers

19

24 Month

19.5% 19.5% Complete (success)
80.5% 80.5% Complete (danger)
$58.470M
avg. $2.436M
$240.823M
avg. $10.034M

Buy/Sell Ratio

0.243

Transactions

151

Filers

21

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers